Latest Breaking News On - Corporate communications investor relations - Page 1 : comparemela.com

Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting

/PRNewswire/ TiumBio Co., Ltd. (Kosdaq: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics.

Sassy Gold Corp.: Sassy Gold Corporate Update

VANCOUVER, BC / ACCESSWIRE / May 31, 2024 / Sassy Gold Corp. (CSE:SASY)(OTCQB:SSYRF)(FSE:4E7) ("Sassy" or "the Company") advises that it has terminated its binding letters of intent (the "LOI's") to acquire

Sassy Gold Corporate Update

VANCOUVER, BC / ACCESSWIRE / May 31, 2024 / Sassy Gold Corp. (CSE:SASY)(OTCQB:SSYRF)(FSE:4E7) ("Sassy" or "the Company") advises that it has terminated its binding letters of intent (the "LOI s") to

Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules